We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Berkshire Hathaway Class A
BRK.A
$1.12T
| $837K | ﹤0.01% |
2
-1
| -33% | -$420K |
|
|
KDMN
2327
DELISTED
Kadmon Holdings, Inc.
KDMN
| $837K | ﹤0.01% |
216,173
-12,259
| -5% | -$47.5K |
|
|
VRAY
2328
DELISTED
ViewRay, Inc.
VRAY
| $833K | ﹤0.01% |
126,162
-21,089
| -14% | -$112K |
|
|
TSC
2329
DELISTED
TriState Capital Holdings, Inc.
TSC
| $832K | ﹤0.01% |
40,825
-3,628
| -8% | -$82.7K |
|
|
ZYXI
2330
DELISTED
Zynex
ZYXI
| $831K | ﹤0.01% |
58,863
-649
| -1% | -$8.97K |
|
2331
Annexon
ANNX
$886M
| $829K | ﹤0.01% |
36,806
+11,410
| +45% | +$253K |
|
2332
Daktronics
DAKT
$1.04B
| $827K | ﹤0.01% |
125,557
-1,555
| -1% | -$10.2K |
|
2333
Atossa Therapeutics
ATOS
$23.5M
| $824K | ﹤0.01% |
+8,691
| New | +$460K |
|
|
VRS
2334
DELISTED
Verso Corporation
VRS
| $823K | ﹤0.01% |
46,494
-9,325
| -17% | -$154K |
|
|
OLP
2335
One Liberty Properties
OLP
$527M
| $818K | ﹤0.01% |
28,826
-3,317
| -10% | -$85.7K |
|
2336
Future Fuel
FF
$223M
| $817K | ﹤0.01% |
85,130
-5,219
| -6% | -$63.1K |
|
2337
Lennar Class B
LEN.B
$20.8B
| $806K | ﹤0.01% |
10,406
-1,174
| -10% | -$88.7K |
|
2338
Tucows
TCX
$175M
| $806K | ﹤0.01% |
10,030
-877
| -8% | -$69.5K |
|
|
TRUE
2339
DELISTED
TrueCar
TRUE
| $806K | ﹤0.01% |
142,604
-37,564
| -21% | -$189K |
|
2340
PMV Pharmaceuticals
PMVP
$63.5M
| $805K | ﹤0.01% |
23,554
+9,536
| +68% | +$319K |
|
|
NGM
2341
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $805K | ﹤0.01% |
40,830
+12,338
| +43% | +$289K |
|
2342
International Seaways
INSW
$4.57B
| $799K | ﹤0.01% |
41,679
-4,056
| -9% | -$78.8K |
|
|
CTT
2343
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $799K | ﹤0.01% |
68,271
-21,340
| -24% | -$248K |
|
|
ACBI
2344
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $797K | ﹤0.01% |
31,300
-3,735
| -11% | -$98.8K |
|
2345
OrthoPediatrics
KIDS
$595M
| $792K | ﹤0.01% |
12,538
-540
| -4% | -$31K |
|
2346
American Outdoor Brands
AOUT
$157M
| $791K | ﹤0.01% |
22,513
-2,299
| -9% | -$67.8K |
|
2347
Nurix Therapeutics
NRIX
$2.65B
| $791K | ﹤0.01% |
29,816
+5,601
| +23% | +$164K |
|
2348
Rigel Pharmaceuticals
RIGL
$750M
| $788K | ﹤0.01% |
18,154
-1,589
| -8% | -$60K |
|
2349
Sportsman's Warehouse
SPWH
$46M
| $784K | ﹤0.01% |
44,133
-1,180
| -3% | -$20.9K |
|
2350
AnaptysBio
ANAB
$1.68B
| $783K | ﹤0.01% |
30,187
-6,752
| -18% | -$162K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.